Mono Pharmacare (NSE:MONOPHARMA) OCF Margin %: 2.49% (As of Sep. 2025)


NSE:MONOPHARMA Mono Pharmacare Ltd NSE:MONOPHARMA
9 GF Score
Price ₹11.00
! 6 Warning Signs
View Full Analysis

What is Mono Pharmacare OCF Margin %?

Mono Pharmacare NSE:MONOPHARMA -1.79% 9 OCF Margin % is 2.49% as of Sep. 2025. GuruFocus rates NSE:MONOPHARMA with a GF Score™ of 9/100. The stock has 6 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Mono Pharmacare ranks worse than 72.29% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Mono Pharmacare's Cash Flow from Operations for the six months ended in Sep. 2025 was ₹17 Mil. Mono Pharmacare's Revenue for the six months ended in Sep. 2025 was ₹663 Mil. Therefore, Mono Pharmacare's OCF Margin % for the quarter that ended in Sep. 2025 was 2.49%.

As of today, Mono Pharmacare's current OCF Yield % is 3.43%.

The historical rank and industry rank for Mono Pharmacare's OCF Margin % or its related term are showing as below:

NSE:MONOPHARMA' s OCF Margin % Range Over the Past 10 Years
Min: -47.46   Med: -2.77   Max: 0.65
Current: 0.46

During the past 5 years, the highest OCF Margin % of Mono Pharmacare was 0.65%. The lowest was -47.46%. And the median was -2.77%.

NSE:MONOPHARMA's OCF Margin % is ranked worse than
72.29% of 664 companies
in the Healthcare Providers & Services industry
Industry Median: 8.255 vs NSE:MONOPHARMA: 0.46

Mono Pharmacare OCF Margin % Related Terms

Mono Pharmacare OCF Margin % Historical Data

* Premium members only.

The historical data trend for Mono Pharmacare's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mono Pharmacare OCF Margin % Chart

Mono Pharmacare Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
OCF Margin %
-2.77 0.65 -47.46 -7.17 -2.56

Mono Pharmacare Semi-Annual Data
Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
OCF Margin % Get a 7-Day Free Trial Premium Member Only -13.25 0.08 -3.82 -1.20 2.49

Mono Pharmacare OCF Margin % Competitor Comparison

For the Pharmaceutical Retailers subindustry, Mono Pharmacare's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mono Pharmacare OCF Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mono Pharmacare's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Mono Pharmacare's OCF Margin % falls into.


NSE:MONOPHARMA
9GF Score
Mono Pharmacare Ltd NSE:MONOPHARMA
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mono Pharmacare OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Mono Pharmacare's OCF Margin for the fiscal year that ended in Mar. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2025 )/Revenue (A: Mar. 2025 )
=-43.028/1683.449
=-2.56 %

Mono Pharmacare's OCF Margin for the quarter that ended in Sep. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Sep. 2025 )/Revenue (Q: Sep. 2025 )
=16.508/662.912
=2.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 2.49% mean?
Mono Pharmacare (NSE:MONOPHARMA) has a OCF Margin % of 2.49% as of Sep. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Mono Pharmacare and its competitors. According to the industry distribution chart, Mono Pharmacare ranks #480 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 72.3%.
Is Mono Pharmacare's OCF Margin % too high?
Mono Pharmacare's current OCF Margin % is 2.49%. The Healthcare Providers & Services industry median OCF Margin % is 8.26. Mono Pharmacare's value of 2.49% is 69.8% below this industry median. Based on the distribution chart, Mono Pharmacare ranks #480 out of 664 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Mono Pharmacare has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Mono Pharmacare's OCF Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Mono Pharmacare ranks #480 out of 664 companies for OCF Margin %. This places Mono Pharmacare in the lower half of its industry. The industry median OCF Margin % is 8.26. Mono Pharmacare's value of 2.49% is 69.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Healthcare Providers & Services company?
The median OCF Margin % among Healthcare Providers & Services companies is 8.26, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mono Pharmacare's current OCF Margin % of 2.49% is 69.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Mono Pharmacare and its competitors. For the Healthcare Providers & Services industry, the median OCF Margin % is 8.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mono Pharmacare's current OCF Margin % is 2.49%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mono Pharmacare stock overvalued right now?
Mono Pharmacare (NSE:MONOPHARMA) has a current OCF Margin % of 2.49%. The current OCF Margin % is 2.49% and 69.8% below the Healthcare Providers & Services industry median of 8.26. Mono Pharmacare's overall GF Score™ is 9/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Mono Pharmacare (NSE:MONOPHARMA), the current OCF Margin % is 2.49% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mono Pharmacare Business Description

Address 1A, Krinkal Apartment, Opposite Mahalaxmi Temple, Paldi, Ahmedabad, GJ, IND, 380007
Mono Pharmacare Ltd distributes a broad range of pharmaceutical products across India. Its portfolio includes antibiotics, antifungal medicines, cough and cold remedies, antacids, analgesics, nutraceuticals, skincare, antiseptics, cardiac and diabetic drugs, and cosmetic items. The company operates through contract manufacturing, sourcing products from various manufacturers and supplying them to healthcare providers and pharmacies. Revenue is generated through the sales and distribution of these pharmaceutical and healthcare products in the Indian market.
9GF Score

Get the complete analysis for NSE:MONOPHARMA

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹11.00
Price